Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

"For participants with a kidney transplant with IgAN:~Day 1 through Week 2 visit, patients will take 200 mg once daily (QD) prior to the morning meal. At the Week 2 visit, patients will titrate up to 400 mg QD and take this dose through Week 36, if tolerated and determined to be safe by the Investigator.~For participants with a kidney transplant with FSGS:~Day 1 through Week 2 visit, patients will take 400 mg QD prior to the morning meal. At the Week 2 visit, patients will titrate up to 800 mg QD and take this dose through Week 36, if tolerated and determined to be safe by the Investigator."